Company intelligence / Profile preview

Diatech Diabetes

Memphis, Tennessee, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Diatech Diabetes developed SMARTFUSION™, a software monitoring system for insulin pumps which demonstrated ~96–97% infusion failure detection accuracy in preclinical studies with major commercial pumps. Published with Stanford University and reported substantial industry awards and grants

Therapeutic areas: Endocrinology
Modalities: DeviceSoftware
Industry: Digital Health Medical Devices

Partnerships

Collaborations with Stanford University, Breakthrough T1D (formerly JDRF), National Institutes of Health (NIH), American Diabetes Association (ADA), Diabetes Center Berne

Beyond the preview

Go deeper on Diatech Diabetes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diatech Diabetes.

Explore the full profile